ebook img

CE in Biotechnology: Practical Applications for Protein and Peptide Analyses PDF

102 Pages·2001·6.069 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview CE in Biotechnology: Practical Applications for Protein and Peptide Analyses

eN IA An International Journal for Rapid Communication in Chromatography, Electrophoresis, and Associated Techniques Abstracted in Anal. Abstr., ASCA. Biodet. Abstr., BioI. Abstr., Cadscan, Chern. Abstr., Chern. Cit. Ind., c.I.S. Abstr., Current Contents, Deep Sea Res. & Oceanogr. Abstr., Diary Sci. Abstr., Excep. Med., Food Sci. & Techn. Abstr., GeoRef., INIS Atorrnind. Ind. Sci. Rev., Ind. Vet., Lead Abstr., Mass Spectr. Bull., Nat. Sci. Cit. Ind., Rev. Med. & Vet. Mycol., Sci. Cit. Ind., Sel. Water Res. Abstr., Sugar Ind. Abstr., Vet. Bull., VITIS, Weed Abstr., W.R.C. Inf., Zine Scan Volume 53, Supplement 2001 Scientific Editors T. A. Berger K.-S. Boos H. Engelhardt Berger Instruments Inc. Institut fur Klinische Chemie Instrumentelle Analytik - Umweltanalytik 123A Sandy Drive Klinikum der Universitat M un chen Universitat des Saarlandes, Newark, DE 19713, USA 81366 Munchen 66041 Saarbriicken, Germany Technical Editors E. R. Adlard, Delryn, Vicarage Lane, I. W. Davies, 78 Blinco Grove Burton, South Wirral CH64 5TJ, UK Cambridge CB 1 7TS, UK K. D. Altria, Analytical Evaluation Gp. R. Stock, 23 Highbury Road, Glaxo R&D, Ware, Herts SG 12 ODP, UK Keyworth, N otts., N G 12 5JB, UK Editorial Advisory Board K.Albert C. A. Cramers P. R. Haddad A. Mosandl R.M. Smith Tubingen, Germany Eindhoven, The Netherlands Hobart, Australia Frankfurt, Germany Loughborough, UK S. Allenmark J. Crommen W. S. Hancock P. Myers J. Stobaugh Goteborg, Sweden Liege, Belgium San Jose, CA, USA Bromborough, UK Lawrence, KS, USA D. W. Armstrong V. A. Davankov H.Irth T. Nakagawa N. Tanaka Rolla, MO, USA Moscow, Russia Amsterdam, The Netherlands Kyoto, Japan Kyoto, Japan G. Baram F. Dondi K.Jinno Sz. Nyiredy L. T. Taylor Irkutsk, Russia Ferrara, Italy Toyohashi, Japan Budakalasz, Hungary Blacksburg, VA. USA D. Barcelo W. Engewald J.A.Jonsson D. Perrett S. Terabe Barcelona, Spain Leipzig. Germany Lund. Sweden London. UK Hyogo. Japan K. D. Bartle F. Erni B. L. Karger C. F. Poole C. Vigh Leeds, UK Locamo, Switzerland Boston, MA, USA Detroit, MI, USA Houston, TX, USA E. Bayer S. Fanali W. Th. Kok H. Poppe B. Wenclawiak Tubingen, Germany Monterotondo Scalo.ltaly Amsterdam. The Netherlands Amsterdam, The Netherlands Siegen, Germany H. Becker E. Francotte M. L. Lee J. M. Ramsey D. Westerlund Saarbrucken, Germany Basel, Switzerland Provo, UT, USA Oak Ridge, TN, USA U ppsala, Sweden G.Bonn H. Frank H. Liebich M.-L. Riekkola I. D. Wilson Innsbruck, Austria Bayreuth, Germany Tubingen, Germany Helsinki, Finland Macclesfield, UK U. A. Th. Brinkman J. L. Garrido W. Lindner J. Roeraade W.H.Wilson Amsterdam, The Netherlands Vigo, Spain Vienna, Austria Stockholm, Sweden Wilmington, DE, USA H. Briickner E.Gelpi H. Lingeman P. Sandra E. S. Yeung Giessen, Germany Barcelona, Spain Amsterdam. The Netherlands Ghent, Belgium Ames, lA, USA K. Cabrera T. Greibrokk F. Lottspeich P. J. Schoenmakers Darmstadt, Germany Oslo, Norway Martinsried, Germany Amsterdam, The Netherlands P. W. Carr E. Grushka M. D. Luque de Castro P. Schreier Minneapolis. MN, USA Jerusalem. Israel Cordoba. Spain Wurzburg. Germany D. Corradini G. Guiochon M. Martin A. M. Siouffi Rome,ltaly Knoxville. TN, USA Paris, France Marseille, France Honorary Editorial Board L. S. Ettre G. Machata c. S. G. Phillips B. Sebille E. Smolkova-Keulemansova Bridgeport, CT, USA Vienna, Austria Oxford, UK Thiais, France Prague, Czech Republic W. Haerdi R. L. Munier L. Rohrschneider P.A. Sewell L. Szepesy Geneva, Switzerland Paris, France Munster, Germany Ormskirk, UK Budapest, Hungary K.-P. Hupe H.M. McNair G. Schomburg C. F. Simpson K. Tesarik Baden-Baden. Germany Blacksburg, VA, USA Mulheim. Germany London. UK Bmo. Czech Republic E.Jellum Oslo, Norway Editorial OHice M.Schaub,Manager H. Weinheimer, Publisher Vieweg Publishing P.O. Box 1546 ~ 65173 Wiesbaden, Germany Tel. +49 (0)6117878 380,381 vleweg Fax +49(0)6117878439 eN HIA An International Journal for Rapid Communication in Chromatography, Electrophoresis, and Associated Techniques Contents Supplement Vol. 53, 2001 Chromatographia CE Series 4 Lse of Capillary Electrophoresis to Determine Series Editor: Kevin D. Altria. Analytical Evaluation the Dilute Protein Concentration in Formulations Group, Glaxo R&D. Ware. Herts SG 12 ODP. UK Containing Interfering Excipients . . . . . . . . . . . . . . . .. S -34 S. S. Park I A. Cate I B. S. Chang CE in Biotechnology: Practical Applications for Protein 4.1 Abstract........ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. S -34 and Peptide Analyses 4.2 Introduction................................... S -34 Edited by Anthony B. Chen, 4.3 Material and Methods .......................... S -35 Genentech Inc. South San Francisco, CA, USA 4.4 Result and Discussion. . . . . . . . . . . . . . . . . . . . . . . . . .. S -35 Wassim Nashabeh 4.5 Conclusion.................................... S -38 Genentech Inc. South San Francisco, CA, USA 4.6 Acknowledgements............................. S -38 4.7 References..................................... S-38 Timothy Wehr Bay Bioanalytical Laboratory. Richmond, CA, USA 5 Effects of the Solution Environment on the Resolution of Recombinant Human Preface ........................................... . S-5 Deoxyribonuclease Variants in Capillary Zone Electrophoresis. . . . . . . . . . . . . . . . . . . . . . . . . . .. S -39 Capillary Electrophoresis in the Development C. P. Quan I E. Canova-Davis I A. B. Chen of Recombinant Protein Biopharmaceuticals ....... . S -7 5.1 Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. S -39 A. B. Chen I E. Canova-Davis 5.2 Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. S -39 1.1 Summary .................................... . S-7 5.3 Materials. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. S -39 1.2 Introduction ................................. . S-7 5.4 Methods ...................................... S -40 1.3 Capillary Electrophoresis Reviews .............. . S-8 5.5 Results and Discussion. . . . . . . . . . . . . . . . . . . . . . . . .. S -40 1.4 Reviews of CE U sed for the Analysis 5.6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. S -44 of Recombinant Proteins ....................... . S-II 5.7 Acknowledgements...... ..... .............. .... S-44 1.5 Recent CE Literature .......................... . S -13 5.8 References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. S -44 1.6 Quality Control and Validation ................. . S-15 1.7 DevelopmentsinCE-MS ....................... . S -15 6 Recent Advances in Capillary Isoelectric Focusing 1.8 References .................................... . S-16 T. Wehr I R. Rodriguez-Diaz 1M. Zhu ............ S-45 6.1 Introd uction .................................. . S-45 2 Selection of Buffers in Capillary Zone Electrophoresis: 6.2 Theory and Practice of clEF .................... . S-45 Application to Peptide and Protein Analysis ........ . S -18 6.3 clEF in Microchannels ......................... . S-47 G. M. Janini/H. J. Issaq 6.4 Imaging clEF ................................. . S-48 2.1 Introduction .................................. . S-18 6.5 clEF-Mass-Spectrometry ....................... . S-49 2.2 Buffer Parameters ............................. . S -18 6.6 Capillary Isoelectric Focusing of Monoclonal 2.3 Buffers Used for the Separation of Peptides Antibodies .................................... . S-50 and Proteins .................................. . S-23 6.7 Capillary Isoelectric Focusing of Hemoglobin 2.4 Acknowledgements ............................ . S-25 and Hemoglobin Variants ...................... . S-54 2.5 References .................................... . S-25 6.8 Capillary Isoelectric Focusing of Erythropoietin ... . S-57 6.9 Novel Applications of clEF ..................... . S-57 3 Reverse-Phase High Performance Liquid 6.10 References .................................... . S-58 Chromatography and Capillary Zone Electrophoresis Separation of Protegrin Analogs ..... S-27 7 Separation of Enbrel® (rhuTNFR: Fc) Isoforms J. Chen I J. Fausnaugh-Pollitt by Capillary Isoelectric Focusing ................. . S-59 3.1 Abstract ...................................... . S-27 C. Jochheim I S. Novick I A. Balland I 3.2 Introduction .................................. . S-27 J. Mahan-Boyce I W.-c. Wang I A. Goetze I 3.3 Experimental ................................. . S-28 W. Gombotz 3.4 Results and Discussion ......................... . S-29 7.1 Abstract ...................................... . S-59 3.5 References .................................... . S-33 7.2 Introduction .................................. . S-59 7.3 Experimental ................................. . S-60 S-2 Chromatographia Supplement Vol. 53,200 I Contents 7.4 Results and Discussion ......................... . S-61 9.3 Capillary Isoelectric Focusing (clEF) ............ . S-81 7.5 Acknowledgements ............................ . S-64 9.4 Capillary Zone Electrophoresis (CZE) ........... . S-83 7.6 References .................................... . S-65 9.5 Carbohydrate Analysis ......................... . S-84 9.6 Methods ..................................... . S-86 8 Optimization, Validation, and Use of Capillary Gel 9.7 Acknowledgements ............................ . S-89 Electrophoresis for Quality Control Testing 9.8 References .................................... . S-89 of Synagis®, a Monoclonal Antibody .............. . S-66 M. A. Schenerman I S. H. Bowen 10 Sensitive and High Resolution CEIMS/MS for 8.1 Abstract ...................................... . S-66 Protein Identification in Complex Mixtures ........ . S-90 8.2 Introduction .................................. . S-66 W. Tong I J. R. Yates 8.3 Methods ..................................... . S-67 10.1 Introduction .................................. . S-90 8.4 Regulatory Guidance .......................... . S-67 10.2 Approaches to Improve the Sensitivity 8.5 Optimization Strategy .......................... . S-68 ofCE/MS/MS for Protein Identification .......... . S-90 8.6 Validation .................................... . S-68 10.3 Approaches to Improve the Resolution 8.7 Validation Parameters for CGE ................. . S-68 of CE/MS/MS for Protein Identification .......... . S-94 8.8 Acknowledgements ............................ . S-72 10.4 Other Approaches ............................. . S-96 8.9 References .................................... . S-72 10.5 Conclusions .................................. . S-97 10.6 References .................................... . S-98 9 Analysis of Protein Therapeutics by Capillary Electrophoresis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. S -75 Subject Index .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. S -100 S. Ma/W. Nashabeh 9.1 Introduction................................... S-75 Abbreviations ...................................... S -102 9.2 Capillary Electrophoresis - Sodium Dodecylsulfate (CE-SDS) ..................................... S-75 Contents Chromatographia Supplement Vol. 53, 2001 S-3 1..d.1 Vol. 53, Supplement 2001 ,I ,.!,- CHROMATOGRAPHIA Chromatographia was founded by R. E. Kaiser in 1968. Publisher Chromatographia is published by Friedr. Vieweg & Sohn Verlagsgesellschaft mbH, P.O. Box 1546, D-65173 Wiesbaden, Fedcral Republic of Germany, Tel. +49 (0)6117878380(-381); Telefax +49(0)611 7878439 Editorial office e-mail: CHROMA [email protected]; webpage: http:\\www.chromatographia.de For more information regarding Viewcg's program for books and journals see our homepage: http://www.vieweg.de Advertising Inquiries concerning advertising should be addressed to the publisher's address above; Tel. +49(0)6117878153, Fax-430. Representatives Inquiries in USA: Trade Media International, 424 Madison Avenue, New York. NY 10017, USA; Tel. (212)421-1229. Inquiries in the UK: Elsevier Science Ltd., The Boulevard. Langford Lane, Kidlington. Oxford. OX5 I GB. UK. Distributors Friedr. Vieweg & Sohn, P.O. Box 1546, D-65173 Wiesbaden, Germany; Tel. +49(0)6117878324; Telefax +49(0)6117878423. Elsevier Science Ltd., The Boulevard, Langford Lane, Kidlington, Oxford. OX5 1G B, UK. Distributions in the USA Chromatographia (USPS No. 374810) is distributed by German Language Publications, Inc .. 153 South Dean Street. Englewood, NJ 07631. Second class postage is paid at Englewood, NJ 07631. Postmaster: send address changes to Chromatographia, German Language Publications, Inc .. 153 South Dean Street, Englewood, NJ 07631. Subscriptions Chromatographia is published monthly. Up to three volumes may be published per year. Vols. 53, 54, Supplements (2001) DM 2.364,- US S 1.243.0() CiS 17.257. sFr 2.103,- C 1.209, - (approx. 2440 pp.) Single copy DM 224.- US S 118.00 CiS 1.635.- sFr 199,- f 115,- For individual subscribers who will certify that Chromatographia is for their personal use only (to be ordered directly from the publisher): Vols. 53, 54, Supplements (2001) DM 1.344,- US S 706.0() CiS 9.811.- sFr 1.196,- C 687, All prices include postage. Subscriptions are renewed automatically for one year unless notice to terminate the subscrip tion is given three months before the end of the current year. Submission of Papers One original and two copies of manuscripts should be sent to Chromatographia. Editorial Office at the same address as the publisher, abovc. For papers intcnded for review-type articles. an outline of the proposed article should first be for warded to the Editorial Office Manager for preliminary discussion. prior to preparation. For general information on the rules concerning style and format of manuscripts please refer to "Instructions to Authors" in every issue. Copyright On publication of a manuscript the exclusive copyright for every language and country passes over to the Publisher. In the USA permission to photocopy for internal or personal use or the internal or personal use of specific clients is granted by the Publisher for libraries and other users registered with the Copyright Clearence Center (CCC), provided that the stated fee per copy is paid directly to the CCc. 21 Congress Street, Salem, MA 01970. Special requests should be addressed to the Publisher. Trademarks The use of general descriptive names, trade names, trademarks, etc., in the publication, even if the former are not espe cially identified, is not to be taken as a sign that such names. as understood by the Trade Marks and Merchandise Marks Act. may accordingly be used freely by anyone. liability Whilst every effort is made by the publisher and editiorial board to see that no inaccurate or misleading data, opinion or statement appears in this journal, they wish to make it clear that the data and opinions appearing in the articles and advertisements herein are the sole responsibility of the contributor or advertiser concerned. Accordingly, the publish ers, the editiorial board and editors and their respective employees, officers and agents accept no responsibility or liabi lity whatsoever for the consequenccs of any such inaccurate or misleading data, opinion or statement. The views ex pressed in the journals book review section are those of the individual over whose name they appear and the Publishers do not necessarily agree with any of the opinions expressed. 1&'1 Friedr. Vieweg & Sohn Verlagsgesellschaft mbH. Braunschweig!Wiesbaden, 2001. Vieweg is a company in the specialist publishing group BertelsmannSpringcr Softcover reprint of the hardcover 1s t edition 2001 ISBN-13: 978-3-322-83023-4 e-ISBN-13 978-3-322-83021-0 001: 10.1007/978-3-322-83021-0 Chromatogram on front page: Gas chromatographic separation of gasoline hydro carbons (selected section of chromatogram) with glass capillary column. S-4 Chromatographia Vol. 53, Supplement 2001 Preface The continuing development of capillary regulatory approval for the routine analy to hold the CE Symposium (in his words, electrophoresis (CE) is evident by the in sis of marketed recombinant protein the time was right), the California Separa creasing number of journal articles, text pharmaceuticals. This meeting demon tion Science Society for sponsoring the books and symposia devoted to CE. This strated that CE has found a niche in the symposium, and Michael Kunitani and monograph is part of a continuing series routine analysis of proteins and peptides SungAe S. Park who were also on the or covering individual areas of CEo A list of in an industrial setting. The editors of this ganizing committee. We would like to topics already published in this series in monograph, along with the series editor thank the symposium participants for cludes: Analysis of nucleic acids by capil (Kevin Altria) were of the opinion that their efforts in preparing manuscripts. lary electrophoresis (edited by Christoph the proceedings of that meeting could pro The editors greatly appreciate the efforts Heller), Analysis of pharmaceuticals by vide the basis for theoretical and practical of Amy Greene-Dittz who reviewed all capillary electrophoresis (written by Ke issues covering the analysis of proteins the figures for the manuscripts, scanned in vin Altria), Analysis of carbohydrates by and peptides by CEo This supplement images when electronic copies were not capillary electrophoresis (written by Aran therefore consists of some of the practical available and modified some images to in Paulus and Antje Klockow-Beck), Capil applications that were presented at the crease their legibility. We would also like lary Electrophoresis: instrumentation and symposium and several review chapters, to thank Angelika Schulz for her patience operation (written by Wim Kok). including 'CE in the development of re and help in assembling this monograph. The Symposium 'CE in Biotechnology: combinant protein biopharmaceuticals', Practical Applications for Protein Analy 'Selection of buffers in CZE: application sis' was held in San Francisco, California, to peptide and protein analysis' and 'Re USA on August 18, 1999. The sympo cent advances in clEF'. Anthony B. Chen sium highlighted practical applications, The editors would like to acknowledge Wassim Nashabeh August 2000 including methods which had obtained Dr Barry L. Karger, who encouraged us Timothy Wehr Preface Chromatographia Supplement Vol. 53,2001 S-5 CHROMATOGRAPHIA CE Series Edited by Kevin D. Altria, Glaxo Wellcome R&D, UK There are currently a number of general • Volume 1: C. Heller (Ed.), Analysis of textbooks covering Capillary Electro Nucleic Acids by Capillary Electro phoresis where information on a range of phoresis applications and techniques can be found. • Volume 2: K. D. Altria, Analysis of Readers who are interested in a specific Pharmaceuticals by Capillary Electro area of CE struggle to find truly compre phoresis hensive treatments of their areas of inter est. The CHROMATOGRAPHIA CE • Volume 3: A. Paulus / A. Klockow series has been established to allow com Beck, Analysis of Carbohydrates prehensive books to be produced covering by Capillary Electrophoresis individual topics. The books are written • Volume 4: W. Kok, Capillary Electro by well known authors in their specialist phoresis: Instrumentation and Operation application areas and cover CE topics such as DNA analysis, analysis of phar • Volume 5: A. B. Chen / W. Nashabeh / maceuticals, chiral separations, MECC, T. Wehr (Eds), CE in Biotechnology: carbohydrate analysis, biomedical appli Practical Applications for Protein and cations and troubleshooting in CEo Peptide Analyses S-6 Chromatographia Supplement Vol. 53, 200 I Capillary Electrophoresis in the Development of Recombinant Protein Biopharmaceuticals A. B. Chen 1 / E. Conovo-Dovis2 Departments of Quality Control I and Analytical Chemistr/, Genentech Inc. One DNA Way, South San Francisco, CA 94080, USA of the protein during various stages of 1.1 Summary production including the crude cell paste or cell culture fluid to determine the yield The understanding of the physicochemical properties of proteins in solution is required to un of the production process. During produc derstand the separations taking place in the capillary. For example, during isoelectric focusing, tion, various post-translational modifica it is important to ensure the lack of protein precipitation during fOCUSing and mobilization tions can occur such as deamidation, oxi otherwise artifacts occur and the true resolution of charge variants is not achieved. Similarly, dation, isoaspartate isomerization, and buffer conditions, including additives, composition of buffer, and pH can influence the resolu proteolytic cleavages. Hence, it may be ne tion of product variants. With diligent efforts one can achieve desired separations. As knowl cessary to analyze for size, charged, or hy edge of buffer conditions and use of these techniques increase, the methods will be improved. drophobic variants, especially if these var MECC can be useful for the characterization of recombinant proteins and monoclonal anti iants have different biological potencies bodies. However, the relatively long analyte migration times may be a deterrent for routine use than the desired product. According to in quality control situations. Pharmaceutical companies will employ new techniques which pro the ICH guideline, Q6B 'Guidance on vide advantages over current technology. CE has advantages in certain applications. Applica Specifications: Test Procedures and Ac tions which use slab gel techniques, IEF and SDS-PAGE can be replaced by the CE methods for ceptance Criteria for Biotechnologicall formulation development, characterization of charge isoforms, and for purity determinations. Biological Products' [I], a product variant CZE and clEF can be used for rapid identity tests which do not require peptide mapping. CZE which does not have the same safety and has a tremendous advantage in analyzing basic proteins, and CZE and CE-SDS can be used efficacy profile as the desired product is to quantify product in the presence of interfering excipients. It is the responsibility of the analyti termed a product-related impurity. For cal chemist to determine applications which are appropriate for CEo It is apparent that these are example, isomerization of a heavy chain currently being defined for the biotechnology industry, and the usage of CE should continue to aspartate residue of a therapeutic mono increase. clonal antibody to isoaspartate resulted in a variant with low potency [2]. The manu facturer may choose to remove these im purities during the purification process or 1.2 Introduction sulin, growth hormone (rhGH), recombi monitor their concentration during lot re nant human erythropoietin (rhEPO), re lease. Since the cloning and expression of insu combinant tissue plasminogen activator Product characterization is required lin, the biotechnology industry has experi (rt-PA), and a number of monoclonal throughout the development of a recombi enced a boom in the number of products antibodies, the required characterization nant product. In early preclinical stages, it that have been developed, tested in clinical and process controls for the approval of a is necessary to confirm ifthe product man trials, and approved for unmet medical protein product are becoming more estab ufactured is the desired product prior to needs for many indications. The develop lished. After the protein has been cloned beginning pharmacokinetic and toxicol ment of proteins as pharmaceuticals is and expressed in eukaryotic or prokary ogical studies. In the case of glycoproteins, somewhat different than the development otic cells, there are usually several rounds there could be heterogeneity due to vary of traditional small molecule pharma of purification, product characterization, ing degrees of glycosylation and occu ceuticals. These differences are mainly due evaluation of the production process, and pancy of glycosylation sites. These varia to the size and complexity of proteins. preclinical and toxicology studies leading tions could affect the intrinsic biological With the experience gained after the ap to the filing of an IND to begin clinical activity of the protein or the pharmacoki proval of recombinant proteins such as in- trials. Assays are required for quantitation netic profiles of these proteins. For exam- Original Chromatographia Supplement Vol. 53,2001 S-7 0009-5893/00102 7-II $ 03.0010 © 2001 Friedr. Vieweg & Sohn Verlagsgesellschaft mbH A. B. Chen et al. (eds.), CE in Biotechnology: Practical Applications for Protein and Peptide Analyses © Friedr. Vieweg & Sohn Verlagsgesellschaft mbH, Braunschweig/Wiesbaden 2001 pie, it has been shown that glycosylation is decylsulfate polyacrylamide gel electro formed by three on-line methods. In the necessary for the antibody-dependent cell phoresis (SDS-PAGE) and isoelectric fo first. sample self-stacking was used to de mediated cytotoxic and complement-de cusing (lEF) methods have been used ex termine trace concentrations of recombi pendent cytotoxic activities of monoclonal tensively for the analysis of recombinant nant interleukins [20]. The second proce antibodies [3]. Carbohydrate moieties play proteins. CE analyses add to the reper dure utilizes solid-phase extraction on a a role in the clearance ofrt-PA [4] and bio toire of available analytical methods and cartridge containing Spherisorb CI8. with logical activity; e. g. type II rt-PA with an will be discussed as they support the re the concentrated pep tides or proteins unoccupied glycosylation site displays quirements for product development. being released with acetonitrile. The latter more in-vitro activity than type I rt-PA method was used to analyze a tryptic di which has all three glycosylation sites oc gest of bovine serum albumin. The third cupied [5]. In these instances, it may be ne 1.3 Capillary method for preconcentration used a semi cessary to monitor glycosylation to de Electrophoresis Reviews permeable hollow fiber between the sam monstrate consistent man ufacture of a ple vial and the capillary inlet. An injec quality product. When the results of clini Several excellent reviews have been writ tion current is applied which concentrates cal trials are promising. more extensive ten in the use of capillary electrophoresis the proteins into the hollow fiber. Subse characterization is usually performed for for the analysis of proteins including bio quently, an electric field is applied regulatory filings to demonstrate that the technology-derived proteins. These re through the hollow fiber to begin the elec manufacturing process is well understood views have provided information based trophoretic separation. This method can in order to avoid surprises when full pro upon the individual capillary electrophor lower the detection limit by a factor of duction occurs. Some of the methods that esis (CE) techniques such as capillary zone 1000 [21]. Because the walls of fused silica are used in characterization are validated electrophoresis (CZE, [6-8]), capillary capillaries carry negative charges due to for final product lot release testing. Ana isoelectric focusing (clEF, [9, 10]), capil ionized silanol groups, some proteins may lytical characterization is also required to lary electrophoresis using sodium dodecyl adsorb to the walls during electrophoresis. support methods for use in the quality sulfate (CE-SDS, [11]) and micellar elec Either dynamic (buffer additives) or static control system. Formulation studies are trokinetic chromatography (MEKC, also (permanently coated) wall coatings are performed to optimize the excipients and called micellar electrokinetic capillary used to reduce adsorption to capillary conditions necessary for the stability of chromatography [MECC], [12]). Reviews walls. For improving the selectivity of a the recombinant protein over a proposed have also been written for the analysis of CZE method, optimizing the composition shelf-life. Formulation studies are also recombinant proteins in general [13-15], of the background electrolyte (BGE) is performed to determine the modes of de antibodies [16], and glycoproteins [17, 18]. usually a more effective procedure with gradation of the protein molecule. Thus, adjusting the pH of the BGE as the first formulation studies normally include ac choice. A considerable amount of re celerated stability studies of the protein 1.3.1 CZE search has been done in describing buffer molecule under various conditions. Fol additives for CZE which minimize pro lowing successful clinical trials and the fi The simplest mode of capillary electro tein-capillary interactions, improve selec nalizing of the manufacturing process, phoresis is that of free solution capillary tivity and resolution. and control electro validation of the methods to be used in the electrophoresis or CZE. In this mode. the osmotic now (EOF). Corradini [22] has quality control of the product is initiated. intrinsic properties of the molecule, its summarized these additives which include The control system for lot release is deter charge and size are used to characterize its neutral polymers, ionic salts and zwitter mined based upon product characteriza electrophoretic behavior, determine its ions. amine modifiers, surfactants, and tion and manufacturing history. Tests for purity, and as a means of quantification. ion-pairing agents used in protein CZE identity, strength, purity, and potency are In Dolnik's review [6] of the CZE of pro methods. In some cases cylcodextrins among those required for final product lot teins, he addressed modeling the migra have been successfully used to resolve pro release. The primary identity test used re tion behavior of proteins, sample pretreat tein mixtures. Thus, carboxymethylated quires peptide mapping to confirm the ments such as preconcentration and der ~-cyclodextrin was used to improve the amino acid sequence of the protein. Iden ivatization to increase sensitivity, meth separation of a model mixture of proteins tity tests are also used to confirm the prod ods to reduce interactions with the capil (::i-chymotrypsinogen A, cytochrome c, uct's identity, for example during packag lary wall, and ways to improve the selec lysozyme, and ribonuclease A) in the cat ing. or transfer of product to collaborators tivity of the method. He also briefly re ionic mode at pH 2.5. and contract labs. Stability studies are re viewed CE-SDS using cross-linked and A fundamental requirement in the quired on bulk and final product to con non-crosslinked gels. When more sensitive analysis of a recombinant protein phar firm the shelf life of the recombinant pro methods than UV detection are required, maceutical is the need to demonstrate duct. laser-induced fluorescence (LIF) or mass identity with respect to its primary amino The traditional chromatographic spectrometry methods have been used. acid sequence by peptide mapping. The methods such as reversed-phase high per The detection limit for bovine serum albu method may also be used to show. by formance liquid chromatography (RP min (BSA) decreases from 0.5 ~lg mL -1 to comparison with an appropriate reference HPLC). size-exclusion chromatography 25 ng mL -1 when UV absorption is re material that changes in the primary ami (SEC), ion-exchange chromatography placed with argon-laser-induced fluores no acid sequence have not occurred, con (both cation and anion), hydrophobic in cence [19]. In his subsequent review, Dol firming product consistency and/or genet teraction chromatography, and gel elec nik [7] updated the information on these ic stability [23]. The method requires con trophoretic methods such as sodium do- same topics. Preconcentration can be per- siderable expertise for performing peptide S-8 Chromatographia Supplement Vol. 53,2001 Original analysis in a quality control environment tides. The peptide analog mobility fit the sample salt levels and protein concentra [23]. At present, only peptide maps gener Offord [26] equation. RPHPLC exhibited tion, and the importance of ampholyte ated by HPLC have been reported to be better separation of single D-amino acid composition depending upon the desired used for regulatory filings. Considerable substitutions, while CZE was better for separation range. Coated capillaries are progress has been made in the analysis of truncated analogs. Thus, RPHPLC and necessary to reduce electroosmotic flow pep tides by CZE, and this is one of the CZE provided orthogonal methods for which would result in band broadening. most promising areas for routine analysis analysis of these peptides. Righetti et al. Once the proteins are focused, they must in quality control. Janini and Issaq in this [8] describe the CZE of peptides and pro be mobilized for detection. Several exam monograph [24] provide the background teins in acidic, isoelectric buffers. These ples are provided for chemical, hydrody for selection of a buffer to perform CZE buffers enable the use of high voltage gra namic, and electro osmotic flow mobiliza analysis of proteins and peptides. This dients (up to 1000 V cm-1) in large bore tion used to monitor the charged iso chapter provides a detailed description of capillaries which produce separations of a forms. Protein precipitation is described buffer basics including temperature and few minutes with high resolution. Thus, as the major source of difficulty in clEF. Joule's heat considerations, buffer type isoelectric aspartic acid (Asp) was used to Reducing the focusing time, lowering the and concentration, and isoelectric buffers. generate a peptide map of trypsin digested protein concentration, and the addition of The authors noted that in CZE some buf ~-casein. The pH of this isoelectric buffer protein-solubilizing agents such as organ fer-capillary wall interactions can enable ranges from 3.36 to 2.80 as its concentra ic modifiers and surfactants are suggested high resolution of pep tides and buffer tion is increased from 5 mM to 50 mM at for reducing protein precipitation. In that analyte interactions can result in different 25°C. Isoelectric Asp (pI 2.77 at 50 mM review the authors presented the clEF of a electrophoretic profiles for the same sam and 25°C) containing 7 M Urea and 0.5% mixture of standard proteins: rt-PA types ple depending upon the buffer system hydroxyethyl cellulose, could be used to I and II, iron-complexed transferrin, and used. The buffers that have been used to analyze storage proteins in cereals such as hemoglobin mutants. Wehr et al. [9] con perform CZE of pep tides and proteins gliadins in wheat and zeins in maize. The cluded that clEF compared favorably were presented, and buffer additives that hydroxyethyl cellulose probably provided with conventional gel IEF in terms of se have been used to enhance resolution of a dynamic coating to prevent the proteins lectivity and analysis time with the added CZE methods, control electroosmotic from adsorbing to the capillary wall. Ver benefit of complete automation. In a sub flow, and reduce analyte adsorption to the zola et al. [28] describe a method for quan sequent review, Rodriguez-Diaz et al. [10] capillary wall were described. MEKC for tifying protein adsorption to bare fused included a discussion on the ampholyte peptide separation is also discussed. Jani silica and for determining the effect of composition, additives which influence ni et al. [25] measured the electrophoretic amino quenchers added to the BGE. The the clEF of proteins, the use of internal mobility of 58 peptides ranging in size method consists of flushing a fluores standards, and presented examples of from 2 to 39 amino acids and varying in cently labeled protein into the capillary, clEF of immunoglobulins and rt-PA charge from 0.63 to 7.82. Measurements equilibrated in Tris-acetate buffer, wherein many aspects of the methodology were obtained with a polyacrylamide pH 5.0, until saturation of binding sites were reviewed in detail. coated capillary using a 50 mM phosphate occurred. SDS micelles are then used to Liu et al. [29] described clEF as a tool buffer, pH 2.5, at 22°C. The results indi electrophoretically desorb the bound pro for examination of pep tides and proteins cated that the Offord model (26) which tein, which is quantified fluorometrically. of pharmaceutical interest. These authors correlates electrophoretic mobility with Using fluorescein isothiocyante (FITC) provided a detailed review of flat-bed IEF the charge-to-size parameter q/ M2/3 pro myoglobin to saturate protein-binding and clEF, including theory and funda vided a good fit of the experimental data. sites, Verzola et al. [28] determined that mentals and a comparison of these meth Endoproteinase Lys-C peptide maps of oligamines (spermidine, spermine, tetra ods. They discussed the chemical nature melittin (26 amino acids) and horse myo ethylenepentamine) were more effective of carrier ampholytes, the formation and globin were compared to theoretical simu than monoamines (triethylamine, trietha stability of pH gradients, and the ratio lations of mobility. The melittin compari nolamine, ethylamine) and diamines (pu nale for their focusing properties and de son was excellent with respect to line posi trescine, cadaverine, hexamethonium bro scribed resolution and peak capacity in tion and relative area percent of the pep mide) in quenching interactions with the clEF. Liu et al. [29] provided examples of tides. The agreement of the theoretical silica wall. Using this method, these inves the cIEF of hemoglobin, transferrin, and e1ectropherogram of myoglobin although tigators also determined that electro monoclonal antibodies. Conti et al. [30] not perfect agreed reasonably well with phoretic desorption with SDS micelles addressed the issue of protein solubility in the experimental data. The chapter by (60 mM) was 100 percent effective for pro clEF, describing a family of protein solu Chen and Fausnaugh-Pollitt [27] in this tein desorption, which was not the case bilizers (non-detergent sulfobetaines in monograph compares the separation of for the commonly used washing proce concentrations up to 1 M) for preventing 33 polycationic protegrin analogs by dures of I M NaOH and 1 M HCI. protein precipitation and aggregation at RPHPLC and CZE. These analogs (14 to the p/value and at low ionic strength. The 18 amino acids in length) consist of single proteins that were used in these studies amino-acid substitutions, truncations, 1.3.2 clEF were L-aspartate oxidase, thermamylase cyclic, and D-amino acid analogs. The (an et-amylase from Bacillus lichenifor separation by CZE used a bare fused-sili Wehr et al. [9] presented an excellent re mis), and alcalase (an alkaline protease of ca capillary and 100 mM sodium phos view on the capillary isoelectric focusing the subtilisin family). Conti et al. [30] sug phate buffer, pH 2.6, and was achieved (clEF) of proteins. They described the in gested that common zwitterions such as due to charge/mass differences of the pep- fluence of sample preparation including taurine and a few of Good's buffers such Original Chromatographia Supplement Vol. 53,2001 S-9 as Bicine and CAPS were useful in acidic and physical gels. An example of a chemi crude E. coli fermentation broth of a re pH gradients up to pH 8.0. Addition of up cal gel is cross-linked polyacrylamide. combinant protein were obtained using a to 20'1<, of sugars. such as saccharose. sor This type of gel is attached to the capillary SO mM sodium borate buffer. pH 9.0. con bitoL and sorbose. improved protein solu wall. Size separation of proteins up to taining 0.3% SDS. The recombinant pro bility near the pI especially if the sugars 35 kDa in molecular weight have been re tein migrated after a large mass of cellular were mixed with 0.2 M taurine. Tran et al. ported in chemical gels. An example of the components which demonstrates the un [31] described a one-step clEF method for powerful capabilities of this system is the usual selectivities that can be obtained resolving the glycoforms of recombinant separation of the two chains of insulin. with MEKC [35]. Another example is the human immunodeficiency virus (HIY) en The disadvantage of the system is that use of MEKC to separate savinase (SAY. velope glycoprotein. rgp 160sMN/LAI. only clean samples can be injected other a serine protease) and SA y* forms which Separation was obtained with a polyvinyl wise the capillaries could clog and result differ from SA Y in a single residue where alcohol (PYA) coated capillary using a in poor separation. Physical gels use non in methionine is replaced by serine [36]. If mixture of narrow and wide-range pH cross-linked linear or slightly branched investigation must be performed on the ampholytes. They determined that a mix polymers as the sieving matrix and are re native protein, MEKC can be conducted ture of a sugar. saccharose and a zwit placed after each run. With the physical under non-denaturing conditions using terion. 3( cyclohexylamino )-I-propanesul gel, pressure injection can also be used as zwitterionic or non-ionic surfactants. The fonic acid was the most efficient additive a means of introducing the sample into work done by James et al. [37] on interfer to avoid protein precipitation. The clEF the capillary. This option is not available on-gamma glycoforms using 400 mM bo method was able to differentiate the rgp with the chemical gels. The noncross rate and 100 mM SDS. pH 8.5, demon 160 glycoform patterns of two sub-popu linked replaceable gel is becoming the pre strated that the glycoform migration lations ofHIY-1. clEF is also reviewed in ferred method for performing size-separa times were inversely related to the amount this monograph by Wehr et al. [32] who tion analyses with CEo These gels are com of associated carbohydrate. The separa provide up-to-date information on am mercially available. Guttman [II] com tion efficiency was a result of the synergis pholyte selection. mobilization tech pared SDS-PAGE and CE-SDS and con tic action of both the reduced electroos niques. the use of internal standards. cluded that similar separation results and motic flow (EOF) and the higher surfac methods for desalting and preventing pro precision can be obtained by either tech tant concentration of the MEKC method tein precipitation, imaged cIEF, and de nique. With respect to molecular weigh as separate entities eliminating protein ad tails of clEF coupled to mass spectrome determination. Guttman [II] presented a sorption. James et al. [37] suggested that try. These authors also review in detail the table comparing slab gel electrophoresis the analytes with the shortest migration clEF of monoclonal antibodies. hemoglo to CE-SDS on 65 individual proteins times had the highest carbohydrate con bin and hemoglobin variants. and eryth ranging in molecular weight from 14- tent and thus the largest glycan structures. ropoietin. 206 kDa. These data clearly showed that As the concentrations of borate and SDS glycoproteins behave anomolously. and if in the buffers were increased, there was an accurate molecular weights were required, increase in resolution observed. and three 1.3.3 CE-SDS the Ferguson method [33] described in main peak groups were resolved. Kats et Guttman's review must be used. However, al. [38] used MECC to separate four major Sodium dodecylsulfate polyacrylamide for recombinant proteins, the CE-SDS isoforms of the BR96 antibody following gel electrophoresis (SDS-PAGE) has been method is used as a general purity test and heat treatment of the molecule in the pres extensively used for the analysis of recom for analysis of production samples in a ence of 25 mM SDS in 12 mM sodium binant proteins during formulation devel similar manner to the use of SDS-PAGE. borate buffer, pH 9.4. These analyses were opment, purification of the product, and In this monograph, the chapter by Sche correlated to changes observed by circular as a general purity test for quality control. nerman and Bowen [34] addresses the op dichroism spectropolarimetry. CE methods based on similar principles timization, validation, and use ofCE-SDS Recently, Miksik and Deyl [39] pub were reviewed by Guttman [II]. The CE in quality control testing. lished their investigation on separation of technique has been called capillary so proteins and peptides in acid buffers con dium dodecylsulfate gel electrophoresis or taining high concentrations of surfactants capillary gel electrophoresis (CGE). The 1.3.4 MEKC (SDS). SDS was used because it has a term. capillary electrophoresis SDS non washing effect on the capillary wall. Sec gel sieving (CE-SDS-NGS), has also been In MEKC/MECC [12], surfactants such ondly, even under acidic conditions SDS used when noncross-Iinked replaceable as SDS are added to the running electro can bind to protein analytes which then matrices were used as the sieving medium. lyte at concentrations above the critical bear considerable negative charge that en In this chapter. CE using SDS for size sep micellar concentration. The electro hances their separation. Apparently this aration of proteins will be referred to sim phoretic migration of proteins is influ system is suitable for proteins which are ply as CE-SDS. Guttman [II] described enced by protein-micelle interactions that soluble in acidic buffers. Separation of the theory of size separation using CE can give a charged micellar characteristic four standard proteins. lactalbumin, cyto SDS and evaluated the effects of opera to a neutral protein. A highly significant chrome c, carbonic anhydrase, and urease tional variables such as field strength, benefit of the presence of surfactant is the was presented as well as the separation ob temperature, capillary dimensions. and elimination of protein-wall interactions. served with a leucocyte lysate prepara separation medium on the method. He re SDS may also induce protein denatura tion. viewed the work performed using two tion, which could facilitate resolution of types of gels that have been used. chemical individual components. Separations of a S-lO Chromatographia Supplement Yol. 53,2001 Original

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.